Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma
Globe Newswire15-02-2023, 21:25
Carolyn Merchant Named Chief Marketing Officer of eXp Realty 6-04-2023, 21:34